These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10859698)

  • 1. Hepatic osteodystrophy: the influence of liver disease and portal hypertension on cytokine activation.
    van der Merwe SW; Attfield D; Fevery J; Bogaerde JB
    Med Hypotheses; 2000 May; 54(5):842-5. PubMed ID: 10859698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic osteodystrophy: outlook good but some problems unsolved.
    Long RG
    Gastroenterology; 1980 Mar; 78(3):644-7. PubMed ID: 6243268
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteopathies and calcium absorption in chronic liver diseases].
    Gossmann HH; Schaumlöffel E; Miller B; Martini GA
    Z Gastroenterol; 1975 Oct; 13(6):594-8. PubMed ID: 1224754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic osteodystrophy: a review.
    Idilman R; de Maria N; Uzunalimoglu O; van Thiel DH
    Hepatogastroenterology; 1997; 44(14):574-81. PubMed ID: 9164540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polycystic hepatic and renal disease with portal hypertension and ascites (a case report)].
    Findor JA; Matute MI; González Cueto D; Benzecry E
    Medicina (B Aires); 1965; 25(6):374-9. PubMed ID: 15154233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic osteodystrophy.
    Goel V; Kar P
    Trop Gastroenterol; 2010; 31(2):82-6. PubMed ID: 20862980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic myelofibrosis complicated by portal hypertension treated with a transjugular intrahepatic portosystemic shunt (TIPS).
    Bĕlohlávek J; Schwarz J; Jirásek A; Krajina A; Polák F; Hrubý M
    Wien Klin Wochenschr; 2001 Mar; 113(5-6):208-11. PubMed ID: 11293952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic and mesenteric sarcoidosis without thoracic involvement: a case of severe noncirrhotic portal hypertension and successful pregnancy.
    Vannozzi G; Tozzi A; Chibbaro G; Mello G; Ponzalli M
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1032-5. PubMed ID: 18787474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glomerulopathies during hepatic disease (author's transl)].
    Nochy D; Druet P
    Nouv Presse Med; 1979 Apr; 8(19):1595-9. PubMed ID: 158744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant hepatomegaly and portal hypertension in an elderly patient with primary liver amyloidosis: an uncommon clinical occurrence.
    Basile G; Villari D; Nicita-Mauro V
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):47-50. PubMed ID: 11409189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic gastrointestinal manifestations of liver disease.
    Cheung RC; Cooper S; Keeffe EB
    Gastrointest Endosc Clin N Am; 2001 Jan; 11(1):15-44. PubMed ID: 11175973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal hypertension in sarcoid liver disease with hypomelanotic skin involvement.
    Mehrotra S; Krishnan PV; Reddy BS; Arora A; Anuradha S; Kar P
    Trop Gastroenterol; 2004; 25(4):168-9. PubMed ID: 15912975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complexity of liver disease; surgical steps toward solution.
    RAVDIN IS
    Ann R Coll Surg Engl; 1957 Feb; 20(2):71-98. PubMed ID: 13403572
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathology of noncirrhotic portal hypertension: clinicopathologic study in pediatric patients.
    Abramowsky C; Romero R; Heffron T
    Pediatr Dev Pathol; 2003; 6(5):421-6. PubMed ID: 14708735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes in chronic liver disease: from old concepts to new evidence.
    Picardi A; D'Avola D; Gentilucci UV; Galati G; Fiori E; Spataro S; Afeltra A
    Diabetes Metab Res Rev; 2006; 22(4):274-83. PubMed ID: 16506276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
    Saab S; Landaverde C; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
    Exp Clin Transplant; 2006 Jun; 4(1):395-9. PubMed ID: 16827633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic osteodystrophy in rats results mainly from portasystemic shunting.
    van der Merwe SW; van den Bogaerde JB; Goosen C; Maree FF; Milner RJ; Schnitzler CM; Biscardi A; Mesquita JM; Engelbrecht G; Kahn D; Fevery J
    Gut; 2003 Apr; 52(4):580-5. PubMed ID: 12631673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver.
    Mallat A; Lotersztajn S
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G9-G12. PubMed ID: 17975129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-cirrhotic portal hypertension associated with autoimmune disease].
    Li X; Gao W; Chen J; Tang W
    Zhonghua Wai Ke Za Zhi; 2000 Feb; 38(2):101-3. PubMed ID: 11831999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.